Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $868.00K in the quarter ending March 31, 2025, with 40.00% growth. This brings the company's revenue in the last twelve months to $2.89M, up 30.23% year-over-year. In the year 2024, Orchestra BioMed Holdings had annual revenue of $2.64M, down -4.42%.

• Revenue (ttm): $2.89M
• Revenue Growth: +30.23%
• P/S Ratio: 35.28
• Revenue / Employee: $41,229
• Employees: 70
• Market Cap: 104.21M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.64M	-122.00K	-4.42%
Dec 31, 2023	2.76M	-773.00K	-21.88%
Dec 31, 2022	3.53M	4.32M	-551.79%
Dec 31, 2021	-782.00K	-6.49M	-113.71%
Dec 31, 2020	5.70M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.